Based on our observations that CAF2 modulates ER-α expression in vivo and estrogen receptor expression and activity in luminal breast cancer cells in vitro, we sought to determine whether CAF2 regulates estrogen-dependence in vivo during tumor initiation and growth. This evidence concerns the gene CNOT8 and breast cancer.